About Metamark Genetics
Metamark is a privately held company dedicated to improving cancer care by providing the next generation of diagnostic and prognostic testing. Since it's founding in 2007 by world leaders in cancer biology, molecular diagnostics and personalized medicine, Metamark has evolved into a leader in clinical proteomics – the study of proteins and protein signatures within healthy and diseased cells. Metamark is a leader in the diagnosis and management of prostate cancer, cancer of the bladder and other urologic conditions.
- Industry : Biotechnology
Product portfolio of Metamark Genetics
News about Metamark Genetics
Here you will find Metamark Genetics, Inc.
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.